PMID- 30058984 OWN - NLM STAT- MEDLINE DCOM- 20181105 LR - 20230804 IS - 2376-1032 (Electronic) IS - 2376-0540 (Print) IS - 2376-0540 (Linking) VI - 24 IP - 8 DP - 2018 Aug TI - Effects of the 2009 USPSTF Depression Screening Recommendation on Diagnosing and Treating Mental Health Conditions in Older Adults: A Difference-in-Differences Analysis. PG - 769-776 LID - 10.18553/jmcp.2018.24.8.769 [doi] AB - BACKGROUND: Depression is a common mental condition in U.S. older adults. To improve rates of underdiagnosis and undertreatment for depression and other mental health conditions in primary care settings, the U.S. Preventive Services Task Force (USPSTF) updates and disseminates its depression screening guideline regularly. OBJECTIVE: To examine the effects of the 2009 USPSTF depression screening recommendation on the 3 following outcomes: diagnoses of mental health conditions, antidepressant prescriptions (overall and potentially inappropriate), and provision of nonpharmacological psychiatric services in office-based outpatient primary care visits made by adults aged 65 or older. METHODS: Data from the 2006-2012 National Ambulatory Medical Care Survey (NAMCS), a nationally representative sample of office-based outpatient primary care visits among older adults (n = 15,596 unweighted), were used. NAMCS represents physician practicing patterns of ambulatory medical care services utilization at the national level. Using a series of multivariate difference-in-differences analyses, we estimated effects of the USPSTF depression screening recommendation on the previously mentioned outcomes by comparing pre- (2006-2009) and post- (2010-2012) periods to describe primary care physician practice patterns. RESULTS: Differences in any mental health diagnosis by the depression screening status were -34.7% in the pre-2009 period and -20.2% in the post-2009 period, resulting in a differential effect of -14.4% (95% CI = -28.2, -0.6; P = 0.040). No differential effect was found in other outcomes. CONCLUSIONS: While there are mixed findings about efficacy and effectiveness of depression screening in the existing literature, more population-based observational research is needed to strengthen and support current USPSTF depression screening recommendation statements in the United States. DISCLOSURES: Funding for this study was provided by the National Institute on Aging of the National Institutes of Health (#T32AG019134). The authors declare that they do not have any conflicts of interest. Publicly available data were obtained from the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC). Analyses, interpretation, and conclusions are solely those of the authors and do not necessarily reflect the views of the Division of Health Interview Statistics or NCHS of the CDC. FAU - Rhee, Taeho Greg AU - Rhee TG AD - 1 Section of Geriatrics, Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut; Yale Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, Connecticut; and Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis. FAU - Capistrant, Benjamin D AU - Capistrant BD AD - 2 School of Social Work, Smith College, Northampton, Massachusetts. FAU - Schommer, Jon C AU - Schommer JC AD - 3 Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis. FAU - Hadsall, Ronald S AU - Hadsall RS AD - 3 Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis. FAU - Uden, Donald L AU - Uden DL AD - 3 Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis. LA - eng GR - T32 AG019134/AG/NIA NIH HHS/United States PT - Comparative Study PT - Journal Article PL - United States TA - J Manag Care Spec Pharm JT - Journal of managed care & specialty pharmacy JID - 101644425 RN - 0 (Antidepressive Agents) SB - IM MH - Aged MH - Aged, 80 and over MH - Ambulatory Care/statistics & numerical data MH - Antidepressive Agents/*therapeutic use MH - Depression/*diagnosis/drug therapy/epidemiology MH - Drug Prescriptions/statistics & numerical data MH - Female MH - Health Care Surveys/*statistics & numerical data MH - Humans MH - Male MH - Mass Screening/*methods/standards MH - Mental Health/*statistics & numerical data/trends MH - Practice Guidelines as Topic MH - Prevalence MH - Primary Health Care/statistics & numerical data MH - Program Evaluation MH - United States/epidemiology PMC - PMC6084471 MID - NIHMS977700 COIS- Funding for this study was provided by the National Institute on Aging of the National Institutes of Health (#T32AG019134). The authors declare that they do not have any conflicts of interest. Publicly available data were obtained from the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC). Analyses, interpretation, and conclusions are solely those of the authors and do not necessarily reflect the views of the Division of Health Interview Statistics or NCHS of the CDC. EDAT- 2018/07/31 06:00 MHDA- 2018/11/06 06:00 PMCR- 2018/08/01 CRDT- 2018/07/31 06:00 PHST- 2018/07/31 06:00 [entrez] PHST- 2018/07/31 06:00 [pubmed] PHST- 2018/11/06 06:00 [medline] PHST- 2018/08/01 00:00 [pmc-release] AID - 10.18553/jmcp.2018.24.8.769 [doi] PST - ppublish SO - J Manag Care Spec Pharm. 2018 Aug;24(8):769-776. doi: 10.18553/jmcp.2018.24.8.769.